Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 145 to 155 of 155 entries
Sorted by: Best Match Show Resources per page
Reactive AA Amyloidosis in the setting of infective endocarditis manifesting as bilateral orbitopathy and choroidopathy.

Retinal cases & brief reports

Carrera W, Rosco MG, Safo M, Peng MY, Ng C, Agarwal A.
PMID: 33394958
Retin Cases Brief Rep. 2020 Dec 18; doi: 10.1097/ICB.0000000000001112. Epub 2020 Dec 18.

PURPOSE: To describe a case of AA amyloidosis which produced an orbital inflammatory response with a novel presentation.METHODS: Case report.RESULTS: A 24 year-old Caucasian female with a history of intravenous (IV) heroin use was hospitalized for tricuspid valve endocarditis...

Cite
Carrera W, Rosco MG, Safo M, et al. Reactive AA Amyloidosis in the setting of infective endocarditis manifesting as bilateral orbitopathy and choroidopathy. Retin Cases Brief Rep. 2020;doi: 10.1097/ICB.0000000000001112.
Carrera, W., Rosco, M. G., Safo, M., Peng, M. Y., Ng, C., & Agarwal, A. (2020). Reactive AA Amyloidosis in the setting of infective endocarditis manifesting as bilateral orbitopathy and choroidopathy. Retinal cases & brief reports, . https://doi.org/10.1097/ICB.0000000000001112
Carrera, William, et al. "Reactive AA Amyloidosis in the setting of infective endocarditis manifesting as bilateral orbitopathy and choroidopathy." Retinal cases & brief reports vol. (2020). doi: https://doi.org/10.1097/ICB.0000000000001112
Carrera W, Rosco MG, Safo M, Peng MY, Ng C, Agarwal A. Reactive AA Amyloidosis in the setting of infective endocarditis manifesting as bilateral orbitopathy and choroidopathy. Retin Cases Brief Rep. 2020 Dec 18; doi: 10.1097/ICB.0000000000001112. Epub 2020 Dec 18. PMID: 33394958.
Copy Download .nbib Format: NLM
Host factors and history of SARS-CoV-2 infection impact the reactogenicity of BNT162b2 mRNA vaccine: results from a cross-sectional survey on 7,014 workers in healthcare.

European review for medical and pharmacological sciences

Ughi N, Del Gaudio F, Dicuonzo A, Orso M, Micheloni G, Puoti M, Pani A, Scaglione F, Zoppini L, Rossetti C, Epis OM, Bellavia G, Giroldi S, Moreno M, Bosio M.
PMID: 34982462
Eur Rev Med Pharmacol Sci. 2021 Dec;25(24):7985-7996. doi: 10.26355/eurrev_202112_27649.

OBJECTIVE: This study aimed to improve the post-marketing surveillance on mRNA anti-SARS-CoV-2 vaccines, characterizing the adverse events (AEs) after the first dose of mRNA BNT162b vaccine. The associations between the AEs and individuals' characteristics were explored.PATIENTS AND METHODS: All...

Cite
Ughi N, Del Gaudio F, Dicuonzo A, et al. Host factors and history of SARS-CoV-2 infection impact the reactogenicity of BNT162b2 mRNA vaccine: results from a cross-sectional survey on 7,014 workers in healthcare. Eur Rev Med Pharmacol Sci. 2021;25(24):7985-7996doi: 10.26355/eurrev_202112_27649.
Ughi, N., Del Gaudio, F., Dicuonzo, A., Orso, M., Micheloni, G., Puoti, M., Pani, A., Scaglione, F., Zoppini, L., Rossetti, C., Epis, O. M., Bellavia, G., Giroldi, S., Moreno, M., & Bosio, M. (2021). Host factors and history of SARS-CoV-2 infection impact the reactogenicity of BNT162b2 mRNA vaccine: results from a cross-sectional survey on 7,014 workers in healthcare. European review for medical and pharmacological sciences, 25(24), 7985-7996. https://doi.org/10.26355/eurrev_202112_27649
Ughi, N, et al. "Host factors and history of SARS-CoV-2 infection impact the reactogenicity of BNT162b2 mRNA vaccine: results from a cross-sectional survey on 7,014 workers in healthcare." European review for medical and pharmacological sciences vol. 25,24 (2021): 7985-7996. doi: https://doi.org/10.26355/eurrev_202112_27649
Ughi N, Del Gaudio F, Dicuonzo A, Orso M, Micheloni G, Puoti M, Pani A, Scaglione F, Zoppini L, Rossetti C, Epis OM, Bellavia G, Giroldi S, Moreno M, Bosio M. Host factors and history of SARS-CoV-2 infection impact the reactogenicity of BNT162b2 mRNA vaccine: results from a cross-sectional survey on 7,014 workers in healthcare. Eur Rev Med Pharmacol Sci. 2021 Dec;25(24):7985-7996. doi: 10.26355/eurrev_202112_27649. PMID: 34982462.
Copy Download .nbib Format: NLM
Pregnancy, Contraception, and Menopause in Advanced Chronic Kidney Disease and Kidney Transplant.

Women's health reports (New Rochelle, N.Y.)

Dines VA, Garovic VD, Parashuram S, Cosio FG, Kattah AG.
PMID: 34841395
Womens Health Rep (New Rochelle). 2021 Oct 25;2(1):488-496. doi: 10.1089/whr.2021.0053. eCollection 2021.

No abstract available.

Cite
Dines VA, Garovic VD, Parashuram S, et al. Pregnancy, Contraception, and Menopause in Advanced Chronic Kidney Disease and Kidney Transplant. Womens Health Rep (New Rochelle). 2021;2(1):488-496doi: 10.1089/whr.2021.0053.
Dines, V. A., Garovic, V. D., Parashuram, S., Cosio, F. G., & Kattah, A. G. (2021). Pregnancy, Contraception, and Menopause in Advanced Chronic Kidney Disease and Kidney Transplant. Women's health reports (New Rochelle, N.Y.), 2(1), 488-496. https://doi.org/10.1089/whr.2021.0053
Dines, Virginia A, et al. "Pregnancy, Contraception, and Menopause in Advanced Chronic Kidney Disease and Kidney Transplant." Women's health reports (New Rochelle, N.Y.) vol. 2,1 (2021): 488-496. doi: https://doi.org/10.1089/whr.2021.0053
Dines VA, Garovic VD, Parashuram S, Cosio FG, Kattah AG. Pregnancy, Contraception, and Menopause in Advanced Chronic Kidney Disease and Kidney Transplant. Womens Health Rep (New Rochelle). 2021 Oct 25;2(1):488-496. doi: 10.1089/whr.2021.0053. eCollection 2021. PMID: 34841395; PMCID: PMC8617582.
Copy Download .nbib Format: NLM
Integrated Safety and Efficacy Among Patients Receiving Benralizumab for Up to 5 Years.

The journal of allergy and clinical immunology. In practice

Korn S, Bourdin A, Chupp G, Cosio BG, Arbetter D, Shah M, Gil EG.
PMID: 34487870
J Allergy Clin Immunol Pract. 2021 Dec;9(12):4381-4392.e4. doi: 10.1016/j.jaip.2021.07.058. Epub 2021 Sep 04.

BACKGROUND: Benralizumab is an IL-5Rα-directed monoclonal antibody indicated for patients with severe, uncontrolled eosinophilic asthma.OBJECTIVE: To evaluate the long-term safety and tolerability of benralizumab among adults treated for up to 5 years.METHODS: This analysis included adults treated with placebo...

Cite
Korn S, Bourdin A, Chupp G, et al. Integrated Safety and Efficacy Among Patients Receiving Benralizumab for Up to 5 Years. J Allergy Clin Immunol Pract. 2021;9(12):4381-4392.e4doi: 10.1016/j.jaip.2021.07.058.
Korn, S., Bourdin, A., Chupp, G., Cosio, B. G., Arbetter, D., Shah, M., & Gil, E. G. (2021). Integrated Safety and Efficacy Among Patients Receiving Benralizumab for Up to 5 Years. The journal of allergy and clinical immunology. In practice, 9(12), 4381-4392.e4. https://doi.org/10.1016/j.jaip.2021.07.058
Korn, Stephanie, et al. "Integrated Safety and Efficacy Among Patients Receiving Benralizumab for Up to 5 Years." The journal of allergy and clinical immunology. In practice vol. 9,12 (2021): 4381-4392.e4. doi: https://doi.org/10.1016/j.jaip.2021.07.058
Korn S, Bourdin A, Chupp G, Cosio BG, Arbetter D, Shah M, Gil EG. Integrated Safety and Efficacy Among Patients Receiving Benralizumab for Up to 5 Years. J Allergy Clin Immunol Pract. 2021 Dec;9(12):4381-4392.e4. doi: 10.1016/j.jaip.2021.07.058. Epub 2021 Sep 04. PMID: 34487870.
Copy Download .nbib Format: NLM
FGFR Inhibition Overcomes Resistance to EGFR-targeted Therapy in Epithelial-like Cutaneous Carcinoma.

Clinical cancer research : an official journal of the American Association for Cancer Research

Bernat-Peguera A, Navarro-Ventura J, Lorenzo-Sanz L, da Silva-Diz V, Bosio M, Palomero L, Penin RM, Pérez Sidelnikova D, Bermejo JO, Taberna M, Vilariño N, Piulats JM, Mesia R, Viñals JM, González-Suárez E, Capella-Gutierrez S, Villanueva A, Viñals F, Muñoz P.
PMID: 33262138
Clin Cancer Res. 2021 Mar 01;27(5):1491-1504. doi: 10.1158/1078-0432.CCR-20-0232. Epub 2020 Dec 01.

PURPOSE: Recurrent and/or metastatic unresectable cutaneous squamous cell carcinomas (cSCCs) are treated with chemotherapy or radiotherapy, but have poor clinical responses. A limited response (up to 45% of cases) to EGFR-targeted therapies was observed in clinical trials with patients...

Cite
Bernat-Peguera A, Navarro-Ventura J, Lorenzo-Sanz L, et al. FGFR Inhibition Overcomes Resistance to EGFR-targeted Therapy in Epithelial-like Cutaneous Carcinoma. Clin Cancer Res. 2020;27(5):1491-1504doi: 10.1158/1078-0432.CCR-20-0232.
Bernat-Peguera, A., Navarro-Ventura, J., Lorenzo-Sanz, L., da Silva-Diz, V., Bosio, M., Palomero, L., Penin, R. M., Pérez Sidelnikova, D., Bermejo, J. O., Taberna, M., Vilariño, N., Piulats, J. M., Mesia, R., Viñals, J. M., González-Suárez, E., Capella-Gutierrez, S., Villanueva, A., Viñals, F., & Muñoz, P. (2021). FGFR Inhibition Overcomes Resistance to EGFR-targeted Therapy in Epithelial-like Cutaneous Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research, 27(5), 1491-1504. https://doi.org/10.1158/1078-0432.CCR-20-0232
Bernat-Peguera, Adrià, et al. "FGFR Inhibition Overcomes Resistance to EGFR-targeted Therapy in Epithelial-like Cutaneous Carcinoma." Clinical cancer research : an official journal of the American Association for Cancer Research vol. 27,5 (2021): 1491-1504. doi: https://doi.org/10.1158/1078-0432.CCR-20-0232
Bernat-Peguera A, Navarro-Ventura J, Lorenzo-Sanz L, da Silva-Diz V, Bosio M, Palomero L, Penin RM, Pérez Sidelnikova D, Bermejo JO, Taberna M, Vilariño N, Piulats JM, Mesia R, Viñals JM, González-Suárez E, Capella-Gutierrez S, Villanueva A, Viñals F, Muñoz P. FGFR Inhibition Overcomes Resistance to EGFR-targeted Therapy in Epithelial-like Cutaneous Carcinoma. Clin Cancer Res. 2021 Mar 01;27(5):1491-1504. doi: 10.1158/1078-0432.CCR-20-0232. Epub 2020 Dec 01. PMID: 33262138.
Copy Download .nbib Format: NLM
Deciphering Solvation Effects in Aqueous Binary Mixtures by Fluorescence Behavior of 4-Aminophthalimide: The Comparison Between Ionic Liquids and Alcohols as Cosolvents.

The journal of physical chemistry. B

Crosio MA, Silber JJ, Moran Vieyra FE, Falcone RD, Borsarelli CD, Correa NM.
PMID: 34788537
J Phys Chem B. 2021 Dec 09;125(48):13203-13211. doi: 10.1021/acs.jpcb.1c06569. Epub 2021 Nov 17.

Ionic liquids (ILs) have received attention for many years due to them being very promising as green solvent substitutes, but they are not fully understood, especially their behavior dissolved in other solvents, for example, water. Thus, the goal of...

Cite
Crosio MA, Silber JJ, Moran Vieyra FE, et al. Deciphering Solvation Effects in Aqueous Binary Mixtures by Fluorescence Behavior of 4-Aminophthalimide: The Comparison Between Ionic Liquids and Alcohols as Cosolvents. J Phys Chem B. 2021;125(48):13203-13211doi: 10.1021/acs.jpcb.1c06569.
Crosio, M. A., Silber, J. J., Moran Vieyra, F. E., Falcone, R. D., Borsarelli, C. D., & Correa, N. M. (2021). Deciphering Solvation Effects in Aqueous Binary Mixtures by Fluorescence Behavior of 4-Aminophthalimide: The Comparison Between Ionic Liquids and Alcohols as Cosolvents. The journal of physical chemistry. B, 125(48), 13203-13211. https://doi.org/10.1021/acs.jpcb.1c06569
Crosio, Matias A, et al. "Deciphering Solvation Effects in Aqueous Binary Mixtures by Fluorescence Behavior of 4-Aminophthalimide: The Comparison Between Ionic Liquids and Alcohols as Cosolvents." The journal of physical chemistry. B vol. 125,48 (2021): 13203-13211. doi: https://doi.org/10.1021/acs.jpcb.1c06569
Crosio MA, Silber JJ, Moran Vieyra FE, Falcone RD, Borsarelli CD, Correa NM. Deciphering Solvation Effects in Aqueous Binary Mixtures by Fluorescence Behavior of 4-Aminophthalimide: The Comparison Between Ionic Liquids and Alcohols as Cosolvents. J Phys Chem B. 2021 Dec 09;125(48):13203-13211. doi: 10.1021/acs.jpcb.1c06569. Epub 2021 Nov 17. PMID: 34788537.
Copy Download .nbib Format: NLM
Circulating Extracellular Vesicles Are Associated with Disease Severity and Interleukin-6 Levels in COPD: A Pilot Study.

Journal of clinical medicine

Nieri D, Daniele M, Lombardi S, Bazzan E, Santerini S, De Cusatis G, Vagaggini B, Cosio MG, Saetta M, Paggiaro P, Celi A, Neri T.
PMID: 34768536
J Clin Med. 2021 Oct 28;10(21). doi: 10.3390/jcm10215014.

Chronic obstructive pulmonary disease (COPD) is a complex condition in which systemic inflammation plays a role in extrapulmonary manifestations, including cardiovascular diseases: interleukin (IL)-6 has a role in both COPD and atherogenesis. The 2011 GOLD document classified patients according...

Cite
Nieri D, Daniele M, Lombardi S, et al. Circulating Extracellular Vesicles Are Associated with Disease Severity and Interleukin-6 Levels in COPD: A Pilot Study. J Clin Med. 2021;10(21)doi: 10.3390/jcm10215014.
Nieri, D., Daniele, M., Lombardi, S., Bazzan, E., Santerini, S., De Cusatis, G., Vagaggini, B., Cosio, M. G., Saetta, M., Paggiaro, P., Celi, A., & Neri, T. (2021). Circulating Extracellular Vesicles Are Associated with Disease Severity and Interleukin-6 Levels in COPD: A Pilot Study. Journal of clinical medicine, 10(21), . https://doi.org/10.3390/jcm10215014
Nieri, Dario, et al. "Circulating Extracellular Vesicles Are Associated with Disease Severity and Interleukin-6 Levels in COPD: A Pilot Study." Journal of clinical medicine vol. 10,21 (2021). doi: https://doi.org/10.3390/jcm10215014
Nieri D, Daniele M, Lombardi S, Bazzan E, Santerini S, De Cusatis G, Vagaggini B, Cosio MG, Saetta M, Paggiaro P, Celi A, Neri T. Circulating Extracellular Vesicles Are Associated with Disease Severity and Interleukin-6 Levels in COPD: A Pilot Study. J Clin Med. 2021 Oct 28;10(21). doi: 10.3390/jcm10215014. PMID: 34768536; PMCID: PMC8584816.
Copy Download .nbib Format: NLM
Host factors and history of SARS-CoV-2 infection impact the reactogenicity of BNT162b2 mRNA vaccine: results from a cross-sectional survey on 7,014 workers in healthcare.

European review for medical and pharmacological sciences

Ughi N, Del Gaudio F, Dicuonzo A, Orso M, Micheloni G, Puoti M, Pani A, Scaglione F, Zoppini L, Rossetti C, Epis OM, Bellavia G, Giroldi S, Moreno M, Bosio M.
PMID: 34982462
Eur Rev Med Pharmacol Sci. 2021 Dec;25(24):7985-7996. doi: 10.26355/eurrev_202112_27649.

OBJECTIVE: This study aimed to improve the post-marketing surveillance on mRNA anti-SARS-CoV-2 vaccines, characterizing the adverse events (AEs) after the first dose of mRNA BNT162b vaccine. The associations between the AEs and individuals' characteristics were explored.PATIENTS AND METHODS: All...

Cite
Ughi N, Del Gaudio F, Dicuonzo A, et al. Host factors and history of SARS-CoV-2 infection impact the reactogenicity of BNT162b2 mRNA vaccine: results from a cross-sectional survey on 7,014 workers in healthcare. Eur Rev Med Pharmacol Sci. 2021;25(24):7985-7996doi: 10.26355/eurrev_202112_27649.
Ughi, N., Del Gaudio, F., Dicuonzo, A., Orso, M., Micheloni, G., Puoti, M., Pani, A., Scaglione, F., Zoppini, L., Rossetti, C., Epis, O. M., Bellavia, G., Giroldi, S., Moreno, M., & Bosio, M. (2021). Host factors and history of SARS-CoV-2 infection impact the reactogenicity of BNT162b2 mRNA vaccine: results from a cross-sectional survey on 7,014 workers in healthcare. European review for medical and pharmacological sciences, 25(24), 7985-7996. https://doi.org/10.26355/eurrev_202112_27649
Ughi, N, et al. "Host factors and history of SARS-CoV-2 infection impact the reactogenicity of BNT162b2 mRNA vaccine: results from a cross-sectional survey on 7,014 workers in healthcare." European review for medical and pharmacological sciences vol. 25,24 (2021): 7985-7996. doi: https://doi.org/10.26355/eurrev_202112_27649
Ughi N, Del Gaudio F, Dicuonzo A, Orso M, Micheloni G, Puoti M, Pani A, Scaglione F, Zoppini L, Rossetti C, Epis OM, Bellavia G, Giroldi S, Moreno M, Bosio M. Host factors and history of SARS-CoV-2 infection impact the reactogenicity of BNT162b2 mRNA vaccine: results from a cross-sectional survey on 7,014 workers in healthcare. Eur Rev Med Pharmacol Sci. 2021 Dec;25(24):7985-7996. doi: 10.26355/eurrev_202112_27649. PMID: 34982462.
Copy Download .nbib Format: NLM
Telomere Length but Not Mitochondrial DNA Copy Number Is Altered in Both Young and Old COPD.

Frontiers in medicine

Casas-Recasens S, Mendoza N, López-Giraldo A, Garcia T, Cosio BG, Pascual-Guardia S, Acosta-Castro A, Borras-Santos A, Gea J, Garrabou G, Agusti A, Faner R.
PMID: 34901077
Front Med (Lausanne). 2021 Nov 24;8:761767. doi: 10.3389/fmed.2021.761767. eCollection 2021.

Accelerated ageing is implicated in the pathogenesis of respiratory diseases as chronic obstructive pulmonary disease (COPD), but recent evidence indicates that the COPD can have roots early in life. Here we hypothesise that the accelerated ageing markers might have...

Cite
Casas-Recasens S, Mendoza N, López-Giraldo A, et al. Telomere Length but Not Mitochondrial DNA Copy Number Is Altered in Both Young and Old COPD. Front Med (Lausanne). 2021;8:761767doi: 10.3389/fmed.2021.761767.
Casas-Recasens, S., Mendoza, N., López-Giraldo, A., Garcia, T., Cosio, B. G., Pascual-Guardia, S., Acosta-Castro, A., Borras-Santos, A., Gea, J., Garrabou, G., Agusti, A., & Faner, R. (2021). Telomere Length but Not Mitochondrial DNA Copy Number Is Altered in Both Young and Old COPD. Frontiers in medicine, 8761767. https://doi.org/10.3389/fmed.2021.761767
Casas-Recasens, Sandra, et al. "Telomere Length but Not Mitochondrial DNA Copy Number Is Altered in Both Young and Old COPD." Frontiers in medicine vol. 8 (2021): 761767. doi: https://doi.org/10.3389/fmed.2021.761767
Casas-Recasens S, Mendoza N, López-Giraldo A, Garcia T, Cosio BG, Pascual-Guardia S, Acosta-Castro A, Borras-Santos A, Gea J, Garrabou G, Agusti A, Faner R. Telomere Length but Not Mitochondrial DNA Copy Number Is Altered in Both Young and Old COPD. Front Med (Lausanne). 2021 Nov 24;8:761767. doi: 10.3389/fmed.2021.761767. eCollection 2021. PMID: 34901077; PMCID: PMC8652089.
Copy Download .nbib Format: NLM
Natural Course of the Diffusing Capacity of the Lungs for Carbon Monoxide in COPD: Importance of Sex.

Chest

Casanova C, Gonzalez-Dávila E, Martínez-Gonzalez C, Cosio BG, Fuster A, Feu N, Solanes I, Cabrera C, Marin JM, Balcells E, Peces-Barba G, de Torres JP, Marín-Oto M, Calle M, Golpe R, Ojeda E, Divo M, Pinto-Plata V, Amado C, López-Campos JL, Celli BR.
PMID: 33878339
Chest. 2021 Aug;160(2):481-490. doi: 10.1016/j.chest.2021.03.069. Epub 2021 Apr 18.

BACKGROUND: The value of the single-breath diffusing capacity of the lungs for carbon monoxide (Dlco) relates to outcomes for patients with COPD. However, little is known about the natural course of Dlco over time, intersubject variability, and factors that...

Cite
Casanova C, Gonzalez-Dávila E, Martínez-Gonzalez C, et al. Natural Course of the Diffusing Capacity of the Lungs for Carbon Monoxide in COPD: Importance of Sex. Chest. 2021;160(2):481-490doi: 10.1016/j.chest.2021.03.069.
Casanova, C., Gonzalez-Dávila, E., Martínez-Gonzalez, C., Cosio, B. G., Fuster, A., Feu, N., Solanes, I., Cabrera, C., Marin, J. M., Balcells, E., Peces-Barba, G., de Torres, J. P., Marín-Oto, M., Calle, M., Golpe, R., Ojeda, E., Divo, M., Pinto-Plata, V., Amado, C., López-Campos, J. L., & Celli, B. R. (2021). Natural Course of the Diffusing Capacity of the Lungs for Carbon Monoxide in COPD: Importance of Sex. Chest, 160(2), 481-490. https://doi.org/10.1016/j.chest.2021.03.069
Casanova, Ciro, et al. "Natural Course of the Diffusing Capacity of the Lungs for Carbon Monoxide in COPD: Importance of Sex." Chest vol. 160,2 (2021): 481-490. doi: https://doi.org/10.1016/j.chest.2021.03.069
Casanova C, Gonzalez-Dávila E, Martínez-Gonzalez C, Cosio BG, Fuster A, Feu N, Solanes I, Cabrera C, Marin JM, Balcells E, Peces-Barba G, de Torres JP, Marín-Oto M, Calle M, Golpe R, Ojeda E, Divo M, Pinto-Plata V, Amado C, López-Campos JL, Celli BR. Natural Course of the Diffusing Capacity of the Lungs for Carbon Monoxide in COPD: Importance of Sex. Chest. 2021 Aug;160(2):481-490. doi: 10.1016/j.chest.2021.03.069. Epub 2021 Apr 18. PMID: 33878339.
Copy Download .nbib Format: NLM
Sick leave request following anti-COVID-19 vaccine administration is low among healthcare workers: results from a retrospective cross-sectional monocentric study.

European review for medical and pharmacological sciences

Schianchi A, Ughi N, Cassano G, Del Gaudio F, Dicuonzo A, Scaglione F, Alberti PM, Rossetti C, Micheloni G, Zoppini L, Bellavia G, Giroldi S, Moreno M, Russo A, Bosio M, Epis OM.
PMID: 34919220
Eur Rev Med Pharmacol Sci. 2021 Dec;25(23):7218-7222. doi: 10.26355/eurrev_202112_27414.

OBJECTIVE: Anti-COVID-19 vaccines were mainly associated with non-serious adverse events (AEs), whose prevalence was reported to be up to 70% in healthcare workers (HCWs). This may lead to sick leave requests, but this impact has never been quantified. This...

Cite
Schianchi A, Ughi N, Cassano G, et al. Sick leave request following anti-COVID-19 vaccine administration is low among healthcare workers: results from a retrospective cross-sectional monocentric study. Eur Rev Med Pharmacol Sci. 2021;25(23):7218-7222doi: 10.26355/eurrev_202112_27414.
Schianchi, A., Ughi, N., Cassano, G., Del Gaudio, F., Dicuonzo, A., Scaglione, F., Alberti, P. M., Rossetti, C., Micheloni, G., Zoppini, L., Bellavia, G., Giroldi, S., Moreno, M., Russo, A., Bosio, M., & Epis, O. M. (2021). Sick leave request following anti-COVID-19 vaccine administration is low among healthcare workers: results from a retrospective cross-sectional monocentric study. European review for medical and pharmacological sciences, 25(23), 7218-7222. https://doi.org/10.26355/eurrev_202112_27414
Schianchi, A, et al. "Sick leave request following anti-COVID-19 vaccine administration is low among healthcare workers: results from a retrospective cross-sectional monocentric study." European review for medical and pharmacological sciences vol. 25,23 (2021): 7218-7222. doi: https://doi.org/10.26355/eurrev_202112_27414
Schianchi A, Ughi N, Cassano G, Del Gaudio F, Dicuonzo A, Scaglione F, Alberti PM, Rossetti C, Micheloni G, Zoppini L, Bellavia G, Giroldi S, Moreno M, Russo A, Bosio M, Epis OM. Sick leave request following anti-COVID-19 vaccine administration is low among healthcare workers: results from a retrospective cross-sectional monocentric study. Eur Rev Med Pharmacol Sci. 2021 Dec;25(23):7218-7222. doi: 10.26355/eurrev_202112_27414. PMID: 34919220.
Copy Download .nbib Format: NLM
Showing 145 to 155 of 155 entries